Evidence map›Paper›PMID 31016330›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Time for new imaging and therapeutic approaches in cardiac amyloidosis.

Riemer H J A Slart, Andor W J M Glaudemans, Walter Noordzij, Johan Bijzet, Bouke P C Hazenberg, Hans L A Nienhuis

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. A Narrative Review ofBiomedicines · 2022
    Review
  4. Deep-learning-based cardiac amyloidosis classification from early acquired pet images.The international journal of cardiovascular imaging · 2021
    Article
  5. Review
  6. Article
  7. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Riemer H J A SlartMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. r.h.j.a.slart@umcg.nl.
Andor W J M GlaudemansMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Walter NoordzijMedical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Johan BijzetAmyloidosis Center of Expertise, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Bouke P C HazenbergAmyloidosis Center of Expertise, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Hans L A NienhuisAmyloidosis Center of Expertise, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmyloidosisPositron Emission Tomography Computed TomographyAniline CompoundsEchocardiographyHumansMagnetic Resonance ImagingRadionuclide ImagingStilbenes4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbeneAniline CompoundsStilbenes

Identifiers

PMID31016330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.